These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

910 related articles for article (PubMed ID: 32654925)

  • 1. Organoid Models of Tumor Immunology.
    Yuki K; Cheng N; Nakano M; Kuo CJ
    Trends Immunol; 2020 Aug; 41(8):652-664. PubMed ID: 32654925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organoids: new frontiers in tumor immune microenvironment research.
    Yang Y; Cui J; Kong Y; Hou Y; Ma C
    Front Immunol; 2024; 15():1422031. PubMed ID: 39136020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
    Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
    Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment.
    Polak R; Zhang ET; Kuo CJ
    Nat Rev Cancer; 2024 Aug; 24(8):523-539. PubMed ID: 38977835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organoid Models for Precision Cancer Immunotherapy.
    Sun CP; Lan HR; Fang XL; Yang XY; Jin KT
    Front Immunol; 2022; 13():770465. PubMed ID: 35450073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organoid Modeling of the Tumor Immune Microenvironment.
    Neal JT; Li X; Zhu J; Giangarra V; Grzeskowiak CL; Ju J; Liu IH; Chiou SH; Salahudeen AA; Smith AR; Deutsch BC; Liao L; Zemek AJ; Zhao F; Karlsson K; Schultz LM; Metzner TJ; Nadauld LD; Tseng YY; Alkhairy S; Oh C; Keskula P; Mendoza-Villanueva D; De La Vega FM; Kunz PL; Liao JC; Leppert JT; Sunwoo JB; Sabatti C; Boehm JS; Hahn WC; Zheng GXY; Davis MM; Kuo CJ
    Cell; 2018 Dec; 175(7):1972-1988.e16. PubMed ID: 30550791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer organoids and their applications for precision cancer immunotherapy.
    Guan D; Liu X; Shi Q; He B; Zheng C; Meng X
    World J Surg Oncol; 2023 Oct; 21(1):343. PubMed ID: 37884976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
    Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
    Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D Tumor Models and Their Use for the Testing of Immunotherapies.
    Boucherit N; Gorvel L; Olive D
    Front Immunol; 2020; 11():603640. PubMed ID: 33362787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune organoids: from tumor modeling to precision oncology.
    Dao V; Yuki K; Lo YH; Nakano M; Kuo CJ
    Trends Cancer; 2022 Oct; 8(10):870-880. PubMed ID: 35773148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of organoids in creating immune microenvironments and treating gynecological tumors.
    Zhou LF; Liao HY; Han Y; Zhao Y
    J Transl Med; 2024 Sep; 22(1):856. PubMed ID: 39313812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment.
    Picca F; Giannotta C; Tao J; Giordanengo L; Munir HMW; Botta V; Merlini A; Mogavero A; Garbo E; Poletto S; Bironzo P; Doronzo G; Novello S; Taulli R; Bersani F
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-Derived Organoids for Precision Cancer Immunotherapy.
    Grönholm M; Feodoroff M; Antignani G; Martins B; Hamdan F; Cerullo V
    Cancer Res; 2021 Jun; 81(12):3149-3155. PubMed ID: 33687948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organoid technology and applications in cancer immunotherapy and precision medicine.
    Homicsko K
    Curr Opin Biotechnol; 2020 Oct; 65():242-247. PubMed ID: 32603978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.
    Tsai S; McOlash L; Palen K; Johnson B; Duris C; Yang Q; Dwinell MB; Hunt B; Evans DB; Gershan J; James MA
    BMC Cancer; 2018 Mar; 18(1):335. PubMed ID: 29587663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organoids as an Enabler of Precision Immuno-Oncology.
    Zhao J; Fong A; Seow SV; Toh HC
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges.
    Rahman MM; Wells G; Rantala JK; Helleday T; Muthana M; Danson SJ
    Expert Rev Clin Immunol; 2024 Aug; 20(8):821-838. PubMed ID: 38546609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of organoids in precision immunotherapy of lung cancer (Review).
    Tian H; Ren J; Mou R; Jia Y
    Oncol Lett; 2023 Nov; 26(5):484. PubMed ID: 37818130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newly developed 3D in vitro models to study tumor-immune interaction.
    Mu P; Zhou S; Lv T; Xia F; Shen L; Wan J; Wang Y; Zhang H; Cai S; Peng J; Hua G; Zhang Z
    J Exp Clin Cancer Res; 2023 Apr; 42(1):81. PubMed ID: 37016422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study.
    Votanopoulos KI; Forsythe S; Sivakumar H; Mazzocchi A; Aleman J; Miller L; Levine E; Triozzi P; Skardal A
    Ann Surg Oncol; 2020 Jun; 27(6):1956-1967. PubMed ID: 31858299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.